Skip to main content
. 2023 Apr 13;13(4):e068179. doi: 10.1136/bmjopen-2022-068179

Figure 1.

Figure 1

Randomisation, treatment assignment and follow-up of study participants. Immunotherapy included tocilizumab, bevacizumab and interferon alpha and beta. ITT, intention to treat; SOC, standard of care.